Lorenzi, M.; Ebohon, S.; Kissner, J.; Comiskey, J.; Paap, M.; Bouchet, C.; Garnham, A.; Wissinger, E.
Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom. J. Mark. Access Health Policy 2025, 13, 58.
https://doi.org/10.3390/jmahp13040058
AMA Style
Lorenzi M, Ebohon S, Kissner J, Comiskey J, Paap M, Bouchet C, Garnham A, Wissinger E.
Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom. Journal of Market Access & Health Policy. 2025; 13(4):58.
https://doi.org/10.3390/jmahp13040058
Chicago/Turabian Style
Lorenzi, Maria, Stephen Ebohon, Jennifer Kissner, Jedd Comiskey, Mayke Paap, Christine Bouchet, Andy Garnham, and Erika Wissinger.
2025. "Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom" Journal of Market Access & Health Policy 13, no. 4: 58.
https://doi.org/10.3390/jmahp13040058
APA Style
Lorenzi, M., Ebohon, S., Kissner, J., Comiskey, J., Paap, M., Bouchet, C., Garnham, A., & Wissinger, E.
(2025). Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom. Journal of Market Access & Health Policy, 13(4), 58.
https://doi.org/10.3390/jmahp13040058
